A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

November 30, 2018

Conditions
Chronic Stable AnginaDyspneaCoronary Occlusion
Interventions
DEVICE

Biolimus-eluting stent implantation

Recanalization of chronic coronary artery occlusion and subsequent implantation of one or ore Biosensor stents

Trial Locations (19)

1002

Latvian Center of Cardiology Pauls Stradins Clinical University Hospital, Riga

28040

Cardiovascular Institute - Hospital Clinico San Carlos, Madrid

31076

Clinique Pasteur, Toulouse

Rangueil university hospital, Toulouse

33074

Clinique Saint-Augustin, Bordeaux

48960

Hospital Galdakao-Usansolo, Galdakao

64283

Klinikum Darmstadt, Darmstadt

65812

Main Taunus Kliniken, Bad Soden

77405

CH de Lagny, Lagny

79189

Herz-Zentrum Bad Krozingen, Bad Krozingen

91300

Institut Hospitalier Jacques Cartier - ICPS, Massy

95126

Cardiac Catheterization Laboratory and Cardiovascular Interventional Unit Cannizzaro Hospita, Catania

99438

Zentralklinik Bad Berka, Bad Berka

08025

Unidad de Cardiología Intervencionista Hospital de Sant Pau, Barcelona

08036

Hospital Clinic Villaroel, Barcelona

BN2 5BE

Royal Sussex County Hospital - Brighton and Sussex University Hospitals, Brighton

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

LE3 9QP

Department of Cardiovascular Sciences University of Leicester, Leicester

SW7 2AZ

National Heart and Lung Institute Imperial College, London

All Listed Sponsors
collaborator

NHS Research and Development

OTHER_GOV

collaborator

Biosensors International

OTHER

collaborator

Asahi Intecc Co., Ltd.

INDUSTRY

lead

Euro CTO Club

OTHER